Health services and systems: latest news

Health services and systems resources

Health services and systems features

Health services and systems in your own words

  • Going into hospital

    My experiences of hospitalisation are mixed. I’ve been admitted twice in the last six months, both times for a minor operation. However, following the excellent...

    From: In your own words

Health services and systems news from aidsmap

More news

Health services and systems news selected from other sources

  • I Moved Back to Atlanta from Boston, and I've Been Out of HIV Meds for a Month

    HIV care is separate and unequal in America, health activist Mason writes, as "the system of care here feels no urgency around my survival."

    04 June 2019 | The Body
  • US: Nearly 1 in 5 People Living With HIV Have Suboptimal Geographic Access to HIV Care

    Nearly 10% of people living with HIV have to travel more than an hour to access HIV care, and those living in rural counties have drive times more than double that of those in urban counties.

    03 June 2019 | American Journal of Managed Care
  • India: Investing in ART to treat HIV/AIDS

    A new analysis has established that further investment in preventing the spread of HIV/AIDS through ART is one of the 12 best investments that India can make to speed up its achievement of the Sustainable Development Goals.

    27 May 2019 | Deccan Herald
  • Analysis reveals extent of drug industry funding of UK patient organisations

    The researchers call for greater transparency to ensure that industry funding is not unduly influenced by commercial objectives.

    23 May 2019 | The BMJ press release
  • Medicare decides against tighter management of HIV drugs

    The Department of Health and Human Services will continue barring Medicare Part D plans from applying the drug utilization management tools prior authorization and step therapy for beneficiaries taking HIV antiretroviral drugs. A rule proposed in November 2018 would have permitted such practices. Gilead voiced opposition to the original proposal, saying physicians need to have the flexibility to prescribe the right medicines for patients.

    21 May 2019 | BioPharma Dive
  • Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says

    In a bid to maintain its dominance in the HIV market, Gilead Sciences (GILD) allegedly conspired with other drug makers whose medicines were part of a so-called combination cocktail in order to block generic competition, according to a lawsuit filed by AIDS activists and two unions.

    15 May 2019 | STAT
  • What Can the United States Learn from Africa about HIV Epidemic Control?

    In a highly relevant new commentary just published in the New England Journal of Medicine, Wafaa M. El-Sadr, ICAP global director, with co-authors Kenneth H. Mayer, Miriam Rabkin, and Sally Hodder, explore the state of AIDS in America, the barriers that stand in the way of ending this persistent public health threat, and, compellingly, propose strategies and tactics that can be adopted from the progress made toward epidemic control in sub-Saharan Africa to bring HIV under control in the U.S.

    02 May 2019 | ICAP
  • In Ethiopia, A Focus on Multi-Month ART Scripting at Scale Pays Off

    As ministries of health and their partners move to scale up differentiated service delivery (DSD) for HIV treatment, one approach is taking the spotlight. Multi-month scripting (MMS) is a facility-based, individual-focused DSD model, in which recipients of care who are doing well on antiretroviral therapy (ART) receive larger amounts of ART at each visit, enabling their appointments to be spaced at longer intervals. In many countries, MMS is combined with appointment spacing and fast-track approaches to minimize the amount of time that people living with HIV need to spend at health facilities.

    26 April 2019 | ICAP
  • Thousands feared at risk after Mexico reforms HIV+ regime

    Thousands of Mexicans living with HIV or at risk of infection could be left without life-saving services after the government changed the way it funds treatment, according to public health experts and LGBT+ rights advocates.

    18 April 2019 | Reuters
  • Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

    New conversations are starting in HIV care as phase III trials have shown that monthly injections of cabotegravir and rilpivirine (Edurant) are non-inferior to a three-drug pill regimen. In 2018, TheBody asked a range of people living with HIV about their willingness to switch to an injectible, and most had mixed feelings. But even if there's widespread interest in this new way of taking antiretroviral therapy (and most likely also prevention, not too far away), it's important to consider not just the willingness of people to move to this new form of treatment, but whether health care systems and providers in the U.S. are ready to support this innovation.

    16 April 2019 | The Body Pro
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.